Literature DB >> 9815288

Regional expression of disease-related genes in human and monkey retina.

S L Bernstein1, P Wong.   

Abstract

PURPOSE: Although specific genes play a role in regional retinal disease, the correlation of regional gene expression in the disease-affected site has not been previously ascertained. Non-human primates are widely used in models of human retinal function and are theorized to have identical (to human) patterns of expression, but no correlation between primate and human regional retinal gene expression has ever been performed. We wanted to evaluate the pattern of regional gene expression for a number of genes whose dysfunctions are known to selectively affect specific regions of the human retina, and to determine whether patterns of regional gene expression in nonhuman primates correlate with the human.
METHODS: Human and rhesus monkey eyes were dissected into retina, retinal pigment epithelium (RPE)/choroid and isolated RPE. Retinal regions were dissected, total RNA was isolated and northern analysis performed. Complementary DNA (cDNA) probes were prepared from genes associated with regional retinal disease. These genes are: rod opsin, the alpha-subunit of rod phosphodiesterase, RDS-peripherin, rod outer membrane (ROM) protein, ornithine aminotransferase (OAT), choroideremia gene product (CHM), tissue specific inhibitor of metalloproteinases-3 (TIMP-3), and red/green photoreceptor pigment protein. We also compared expression of Norrie disease product (NDP), a gene whose mutation is known to globally affect the retina.
RESULTS: Rod-specific mRNA expression is highest in the retinal midperiphery, and cone-specific mRNA levels were highest in total RNA from the cone-dominant fovea. mRNA levels for genes coding for proteins expressed in both rod- and cone photoreceptors (RDS-peripherin and ROM-1) are also highest in total RNA from the retinal midperiphery. Regional mRNA levels of CHM and OAT do not directly correlate with their patterns of disease expression. NDP mRNA expression was equivalent in both fovea and midperipheral retina total RNA. Patterns of gene expression were qualitatively similar for both human and rhesus monkey retina.
CONCLUSIONS: Regional retinal gene expression is an important factor in regional disease. However, for genes not solely expressed by a single photoreceptor subtype, other factors, such as regional metabolic differences, intra- and intercellular interactions, are also likely to be important in predisposing a single retinal region to disease. The pattern of neural retina OAT mRNA expression may have important implications in determining the appropriate tissue approach in gene therapy for gyrate atrophy. Regional retinal gene expression likely plays a significant, but nonexclusive role in the development of regional retinal disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815288

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  11 in total

1.  Gyrate atrophy: clinical and genetic findings in a female without arginine-restricted diet during her first 39 years of life and report of a new OAT gene mutation.

Authors:  Agnes B Renner; Andreas Walter; Britta S Fiebig; Herbert Jägle
Journal:  Doc Ophthalmol       Date:  2012-06-07       Impact factor: 2.379

2.  Differential gene expression in the developing human macula: microarray analysis using rare tissue samples.

Authors:  Peter Kozulin; Jan M Provis
Journal:  J Ocul Biol Dis Infor       Date:  2009-11-22

3.  Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degeneration.

Authors:  Jason Charng; Artur V Cideciyan; Samuel G Jacobson; Alexander Sumaroka; Sharon B Schwartz; Malgorzata Swider; Alejandro J Roman; Rebecca Sheplock; Manisha Anand; Marc C Peden; Hemant Khanna; Elise Heon; Alan F Wright; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

Review 4.  Promises and pitfalls of evaluating photoreceptor-based retinal disease with adaptive optics scanning light ophthalmoscopy (AOSLO).

Authors:  Niamh Wynne; Joseph Carroll; Jacque L Duncan
Journal:  Prog Retin Eye Res       Date:  2020-11-06       Impact factor: 19.704

5.  OFF bipolar cell density varies by subtype, eccentricity, and along the dorsal ventral axis in the mouse retina.

Authors:  Michael J Camerino; Ian J Engerbretson; Parker A Fife; Nathan B Reynolds; Mikel H Berria; Jamie R Doyle; Mellisa R Clemons; Michael D Gencarella; Bart G Borghuis; Peter G Fuerst
Journal:  J Comp Neurol       Date:  2020-11-09       Impact factor: 3.028

6.  Generation of a foveomacular transcriptome.

Authors:  Alison Ziesel; Steven Bernstein; Paul W Wong
Journal:  Mol Vis       Date:  2014-07-01       Impact factor: 2.367

7.  Hypoxia-regulated components of the U4/U6.U5 tri-small nuclear riboprotein complex: possible role in autosomal dominant retinitis pigmentosa.

Authors:  Rainald Schmidt-Kastner; Hideo Yamamoto; Duco Hamasaki; Hiroko Yamamoto; Jean-Marie Parel; Christoph Schmitz; C Kathy Dorey; Janet C Blanks; Markus N Preising
Journal:  Mol Vis       Date:  2008-01-25       Impact factor: 2.367

8.  Expressed sequence tag analysis of adult human optic nerve for NEIBank: identification of cell type and tissue markers.

Authors:  Steven L Bernstein; Yan Guo; Katherine Peterson; Graeme Wistow
Journal:  BMC Neurosci       Date:  2009-09-24       Impact factor: 3.288

9.  Complexity of the Class B Phenotype in Autosomal Dominant Retinitis Pigmentosa Due to Rhodopsin Mutations.

Authors:  Samuel G Jacobson; David B McGuigan; Alexander Sumaroka; Alejandro J Roman; Michaela L Gruzensky; Rebecca Sheplock; Judy Palma; Sharon B Schwartz; Tomas S Aleman; Artur V Cideciyan
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-09-01       Impact factor: 4.799

10.  Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma.

Authors:  Stephanie A Leopold; Ludwig F Zeilbeck; Gregor Weber; Roswitha Seitz; Michael R Bösl; Herbert Jägle; Rudolf Fuchshofer; Ernst R Tamm; Andreas Ohlmann
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.